PMID- 28087735 OWN - NLM STAT- MEDLINE DCOM- 20170515 LR - 20171217 IS - 1460-2083 (Electronic) IS - 0964-6906 (Linking) VI - 26 IP - 6 DP - 2017 Mar 15 TI - Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice. PG - 1041-1055 LID - 10.1093/hmg/ddx013 [doi] AB - Alterations in the Duchenne muscular dystrophy (DMD) gene have been associated with enhanced stress reactivity in vertebrate species, suggesting a role for brain dystrophin in fear-related behavioral and cognitive processes. Because the loss of dystrophin (Dp427) reduces clustering of central gamma-aminobutyric acid (GABAA) receptors, it is suspected that local inhibitory tuning and modulation of neuronal excitability are perturbed in a distributed brain circuit that normally controls such critical behavioral functions. In this study, we undertook a large-scale behavioral study to evaluate fear-related behavioral disturbances in dystrophin-deficient mdx mice. We first characterized the behavioral determinants of the enhanced fearfulness displayed by mdx mice following mild acute stress and its association with increased anxiety and altered fear memories. We further demonstrated that this enhanced fearfulness induces long-lasting motor inhibition, suggesting that neurobehavioral dysfunctions significantly influence motor outcome measures in this model. We also found that mdx mice are more sensitive to the sedative and hypnotic effects of 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol hydrochlorid (THIP), a selective pharmacological activator of extrasynaptic GABAA receptors involved in central tonic inhibition. Our results highlight that information on the emotional aspects of mdx mice are important to better understand the bases of intellectual and neuropsychiatric defects in DMD and to better define valuable functional readouts for preclinical studies. Our data also support the hypothesis that altered spatial localization of GABAA receptors due to Dp427 loss is a pathological mechanism associated with brain dysfunction in DMD, suggesting that extrasynaptic GABAA receptors might be candidate targets for future therapeutic developments. CI - (c) The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. FAU - Vaillend, Cyrille AU - Vaillend C FAU - Chaussenot, Remi AU - Chaussenot R LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Hum Mol Genet JT - Human molecular genetics JID - 9208958 RN - 0 (Dystrophin) RN - 0 (Isoxazoles) RN - 0 (Receptors, GABA-A) RN - 0 (apo-dystrophin 1) RN - K1M5RVL18S (gaboxadol) SB - IM MH - Animals MH - Brain/*metabolism/physiopathology MH - Cognition/physiology MH - Disease Models, Animal MH - Dystrophin/*genetics/metabolism MH - Fear/physiology MH - GABAergic Neurons/*metabolism/pathology MH - Humans MH - Isoxazoles/administration & dosage MH - Mice MH - Mice, Inbred mdx MH - Muscular Dystrophy, Duchenne/*genetics/physiopathology MH - Receptors, GABA-A/genetics/metabolism MH - Stress, Psychological/*genetics/physiopathology EDAT- 2017/01/15 06:00 MHDA- 2017/05/16 06:00 CRDT- 2017/01/15 06:00 PHST- 2016/10/11 00:00 [received] PHST- 2016/12/30 00:00 [accepted] PHST- 2017/01/15 06:00 [pubmed] PHST- 2017/05/16 06:00 [medline] PHST- 2017/01/15 06:00 [entrez] AID - ddx013 [pii] AID - 10.1093/hmg/ddx013 [doi] PST - ppublish SO - Hum Mol Genet. 2017 Mar 15;26(6):1041-1055. doi: 10.1093/hmg/ddx013.